Streetbeat News

Price Targets

DTE

Ladenburg Thalmann has initiated coverage on DTE Energy with a Buy rating and set a price target of $131.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:50 am

BABA

B of A Securities analyst Eddie Leung maintains a Buy rating on Alibaba Group Holdings (NYSE:BABA) and raises the price target from $103 to $106.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:49 am

TME

B of A Securities analyst Lei Zhang maintains a Buy rating on Tencent Music Entertainment Group (NYSE:TME) but lowers the price target from $18 to $15.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:47 am

HUT

HC Wainwright & Co. has upgraded Hut 8 (NASDAQ:HUT) from Sell to Buy and raised the price target from $7.5 to $13.5.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:46 am

SE

B of A Securities analyst Sachin Salgaonkar maintains a Buy rating on Sea (NYSE:SE) and raises the price target from $77 to $84.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:45 am

DPRO

IBTA

INTU

MDT

NCNO

NRIX

SBUX

SRAD

TJX

WULF

Top Wall Street analysts have updated their outlooks on several US-listed companies, including nCino, Intuit, Medtronic, Draganfly, Starbucks, Ibotta, TJX Companies, TeraWulf, Nurix Therapeutics, and Sportradar Group. These updates include both upgrades and downgrades, with changes in price targets and ratings.

Portfolio Pulse from Avi Kapoor

August 14, 2024 | 11:43 am

MRCY

Baird analyst Peter Arment maintains a Neutral rating on Mercury Systems (NASDAQ:MRCY) and raises the price target from $26 to $37.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:42 am

MRSN

Baird analyst Colleen Kusy maintains a Neutral rating on Mersana Therapeutics (NASDAQ:MRSN) and lowers the price target from $4 to $3.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:41 am

ILMN

Barclays analyst Luke Sergott has upgraded Illumina (NASDAQ:ILMN) from Underweight to Equal-Weight and set a price target of $125.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:40 am

ALHC

Baird analyst Michael Ha maintains an Outperform rating on Alignment Healthcare (NASDAQ:ALHC) and raises the price target from $10 to $11.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:39 am